Publications (287) Publications in which a researcher has participated

2024

  1. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial

    The Lancet Infectious Diseases, Vol. 24, Núm. 4, pp. 375-385

2023

  1. Direct-acting oral anticoagulants in antiphospholipid syndrome: A systematic review

    Medicina Clinica, Vol. 161, Núm. 2, pp. 65-77

  2. Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

    Frontiers in Microbiology, Vol. 14

2022

  1. Complicaciones no infecciosas del paciente con infección por el virus de la inmunodeficiencia humana

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 57, pp. 3345-3352

  2. Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

    World Journal of Hepatology, Vol. 14, Núm. 1, pp. 62-79

  3. Implication of Neutrophils Extracellular Traps in the Pathogenesis of SARS-CoV-2 pneumonia

    Biomedicines, Vol. 10, Núm. 10

  4. Infecciones por el virus del grupo herpes

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 57, pp. 3353-3360

  5. Infección por el virus de la inmunodeficiencia humana

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 57, pp. 3329-3336

  6. Protocolo diagnóstico del paciente inmunocomprometido febril con infiltrados pulmonares

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 53, pp. 3136-3142

  7. Sífilis

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 54, pp. 3145-3156

  8. ¿Es el momento de incluir a las mujeres transexuales como grupo de riesgo para la vacunación frente al virus del papiloma humano?

    Vacunas

2021

  1. Acute hepatitis C virus infection and direct-acting antiviral drugs: Perfect combination to eliminate the epidemic?

    International Journal of STD and AIDS, Vol. 32, Núm. 13, pp. 1257-1260

  2. Association between convalescent plasma treatment and mortality in COVID-19: a collaborative systematic review and meta-analysis of randomized clinical trials

    BMC Infectious Diseases, Vol. 21, Núm. 1

  3. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 7, pp. 1928-1936

  4. Haemophagocytic syndrome and COVID-19

    Clinical Rheumatology, Vol. 40, Núm. 4, pp. 1233-1244

  5. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 9, pp. 1863-1871

  6. Modifications of liver stiffness and CXCL4, TGF-β1 and HGF are similar in HCV- and HIV/HCV-infected patients after DAAs

    Scientific Reports, Vol. 11, Núm. 1

  7. Neutrophil Expression of T and B Immunomodulatory Molecules in HIV Infection

    Frontiers in Immunology, Vol. 12

  8. Similarities and differences between hiv and sars-cov-2

    International Journal of Medical Sciences, Vol. 18, Núm. 3, pp. 846-851

2020

  1. Colitis infecciosa

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 8, pp. 427-433